IQVIA HOLDINGS INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
IQVIA HOLDINGS INC. (IQV) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $976.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-17
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $976.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $881.00M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $911.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $852.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $976.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $881.00M 10-K · filed 2025-02-13 |
| 2023-12-31 | $911.00M 10-K · filed 2024-02-15 |
| 2022-12-31 | $852.00M 10-K · filed 2023-02-15 |
| 2021-12-31 | $826.00M 10-K · filed 2022-02-16 |
| 2020-12-31 | $1.06B 10-K · filed 2021-02-12 |
| 2019-12-31 | $1.07B 10-K · filed 2020-02-18 |
| 2018-12-31 | $1.05B 10-K · filed 2019-02-19 |
| 2017-12-31 | $983.00M 10-K · filed 2018-02-16 |
| 2016-12-31 | $837.00M 10-K · filed 2017-02-16 |
| 2015-12-31 | $61.70M 10-K · filed 2016-02-11 |
| 2014-12-31 | $57.50M 10-K · filed 2015-02-12 |
| 2013-12-31 | $57.30M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |